Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Vieweg, W. V. R.
* Articles by Wood, M. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Vieweg, W. V. R.
* Articles by Wood, M. A.
Related Collections
* Antidepressants
Psychosomatics 45:371-377, October 2004
© 2004 The Academy of Psychosomatic Medicine


Review

Tricyclic Antidepressants, QT Interval Prolongation, and Torsade de Pointes

W. Victor R. Vieweg, M.D., and Mark A. Wood, M.D.

Received April 8, 2003; revision received Aug. 11, 2003; accepted Oct. 17, 2003. From the Department of Psychiatry and the Department of Internal Medicine, Cardiology Division, Medical College of Virginia, Virginia Commonwealth University. Address reprint requests to Dr. Vieweg, Department of Psychiatry, MCV/VCU, 17 Runswick Dr., Richmond, VA 23238-5414; vvieweg{at}vcu.edu (e-mail).

The authors postulate mechanisms linking tricyclic antidepressants, QT interval prolongation, torsade de pointes, and sudden cardiac death. Case reports identify amitriptyline and maprotiline as the tricyclic antidepressants most likely to provoke torsade de pointes. Risk factors of family history of congenital long QT syndrome, age, female sex, metabolic and cardiovascular disease, metabolic inhibitors, hypokalemia, drug overdose, and co-prescription of drugs associated with QT interval prolongation were found in cases of torsade de pointes associated with tricyclic antidepressants. Clinicians should be cautious when prescribing tricyclic antidepressants with other drugs, such as thioridazine, that are capable of prolonging the QT interval.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Chopra, D. Laver, S. S. Davies, and B. C. Knollmann
Amitriptyline Activates Cardiac Ryanodine Channels and Causes Spontaneous Sarcoplasmic Reticulum Calcium Release
Mol. Pharmacol., January 1, 2009; 75(1): 183 - 195.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
W. R. Zemrak and G. A. Kenna
Association of antipsychotic and antidepressant drugs with Q-T interval prolongation
Am. J. Health Syst. Pharm., June 1, 2008; 65(11): 1029 - 1038.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org